Compare · head to head
Akso Health Group vs Innovent Biologics
Innovent Biologics ranks higher overall — 360 rank 68 vs 2.
Innovent Biologics leads on Value (40 vs 32), Quality (67 vs 10), Safety (62 vs 36) and Sentiment (51 vs 34).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Hong Kong SAR China | China |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Biotechnology |
| Size | Small | Large |
| ISIN | US98422P1084 | KYG4818G1010 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 2 | 68 |
| Value | 32 | 40 |
| Quality | 10 | 67 |
| Growth | NR | 49 |
| Safety | 36 | 62 |
| Sentiment | 34 | 51 |
| Quality details | ||
| Profitability | 4 | 60 |
| Cash Truth | 17 | 74 |
Akso Health Group vs Prenetics GlobalAkso Health Group vs Australian Clinical LabsAkso Health Group vs H.U. Group HoldingsAkso Health Group vs TakarasAdd a third stock →
Full analyses: Akso Health Group · Innovent Biologics
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100